Q3 2017 Holdings
Filed 2017-11-14 | 9 holdings | $116.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Kala Pharmaceuticals, Inc. | Common Stock | 483119103 | $43.2K | 1,890,913 | 37.1% |
| Selecta Biosciences, Inc.(SELBUSD) | Common Stock | 816212104 | $29.7K | 1,627,527 | 25.5% |
| Fate Therapeutics, Inc.(FATE) | Common Stock | 31189P102 | $9.8K | 2,473,186 | 8.4% |
| Atyr Pharma Inc.(LIFEUSD) | Common Stock | 002120103 | $9.2K | 1,827,992 | 7.9% |
| T2 Biosystems, Inc. | Common Stock | 89853L104 | $7.9K | 1,875,524 | 6.8% |
| Pulmatrix Inc. | Common Stock | 74584P103 | $7.4K | 3,607,996 | 6.4% |
| Trevena, Inc. | Common Stock | 89532E109 | $5.2K | 2,053,540 | 4.5% |
| Genocea Biosciences, Inc. | Common Stock | 372427104 | $2.9K | 1,968,606 | 2.5% |
| Dare Bioscience, Inc.(CERUEUR) | Common Stock | 23666P101 | $1.0K | 328,752 | 0.9% |